Regina A. Oyesanya, Ph.D.
Affiliations: | 2009 | Virginia Commonwealth University, Richmond, VA, United States |
Area:
Biochemistry, Molecular BiologyGoogle:
"Regina Oyesanya"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Xianjun Fang | grad student | 2009 | VCU | |
| (Molecular mechanisms for regulation of gene expression by lysophosphatidic acid in ovarian carcinoma cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Oyesanya RA, Bhatia S, Menezes ME, et al. (2014) MDA-9/Syntenin regulates differentiation and angiogenesis programs in head and neck squamous cell carcinoma. Oncoscience. 1: 725-37 |
| Hedvat M, Emdad L, Das SK, et al. (2012) Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules. Anti-Cancer Agents in Medicinal Chemistry. 12: 1143-55 |
| Das SK, Bhutia SK, Kegelman TP, et al. (2012) MDA-9/syntenin: a positive gatekeeper of melanoma metastasis. Frontiers in Bioscience (Landmark Edition). 17: 1-15 |
| Quinn BA, Dash R, Azab B, et al. (2011) Targeting Mcl-1 for the therapy of cancer. Expert Opinion On Investigational Drugs. 20: 1397-411 |
| Dumur CI, Campbell DJ, DeWitt JL, et al. (2010) Differential gene expression profiling of cultured neu-transformed versus spontaneously-transformed rat cholangiocytes and of corresponding cholangiocarcinomas. Experimental and Molecular Pathology. 89: 227-35 |
| Zhang Z, Oyesanya RA, Campbell DJ, et al. (2010) Preclinical assessment of simultaneous targeting of epidermal growth factor receptor (ErbB1) and ErbB2 as a strategy for cholangiocarcinoma therapy. Hepatology (Baltimore, Md.). 52: 975-86 |
| Oyesanya RA, Greenbaum S, Dang D, et al. (2010) Differential requirement of the epidermal growth factor receptor for G protein-mediated activation of transcription factors by lysophosphatidic acid. Molecular Cancer. 9: 8 |
| Song Y, Wu J, Oyesanya RA, et al. (2009) Sp-1 and c-Myc mediate lysophosphatidic acid-induced expression of vascular endothelial growth factor in ovarian cancer cells via a hypoxia-inducible factor-1-independent mechanism. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 492-501 |
| Oyesanya RA, Lee ZP, Wu J, et al. (2008) Transcriptional and post-transcriptional mechanisms for lysophosphatidic acid-induced cyclooxygenase-2 expression in ovarian cancer cells. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 2639-51 |
| Song Y, Wilkins P, Hu W, et al. (2007) Inhibition of calcium-independent phospholipase A2 suppresses proliferation and tumorigenicity of ovarian carcinoma cells. The Biochemical Journal. 406: 427-36 |